CAS: 1256341-22-6
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | CX08005 REF: IN-DA01FGAHCAS: 1256341-22-6 | 98% | To inquire | Wed 22 Jan 25 |
 | CX08005 REF: 3D-GAC34122CAS: 1256341-22-6 | Min. 95% | To inquire | Wed 05 Mar 25 |
 | CX08005 REF: TM-T37184CAS: 1256341-22-6 | ≥98% | 91.00 €~2,354.00 € | Wed 12 Mar 25 |
Ref: IN-DA01FGAH
| 5mg | 174.00 € | ||
| 10mg | 312.00 € | ||
| 25mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Wednesday 22 Jan 2025
CX08005
CAS:1256341-22-6
CX08005 is a phosphatase inhibitor that has been shown to increase the activity of acetyl-CoA …
Formula:
C28H39NO4
Purity:
Min. 95%
Molecular weight:
453.6 g/mol
Ref: 3D-GAC34122
| 25mg | 875.00 € | ||
| 50mg | 1,317.00 € | ||
| 100mg | 1,833.00 € |
Estimated delivery in United States, on Wednesday 5 Mar 2025
CX08005
CAS:1256341-22-6
CX08005 inhibits PTP1B, cuts liver fat, and improves microcirculation in NAFLD.
Formula:
C28H39NO4
Purity:
≥98%
Color and Shape:
Solid
Molecular weight:
453.61
Ref: TM-T37184
| 1mg | 91.00 € | ||
| 5mg | 213.00 € | ||
| 10mg | 329.00 € | ||
| 25mg | 616.00 € | ||
| 50mg | 871.00 € | ||
| 100mg | 1,171.00 € | ||
| 500mg | 2,354.00 € |
Estimated delivery in United States, on Wednesday 12 Mar 2025
